by ComplianceQuest

Inspection Tracker

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

FDA Guidance Global Templates

Start with a Free ConsultationBook 30 minutes with a ComplianceQuest specialist.Book a Call

Sign In Create a Free Account

Big News: FDA is moving from MasterControl to ComplianceQuest.See Why

Search AgentQ/

Talk to a Specialist

Loading…

My DashboardInspection TrackerForm 483sAuronext Pharma

Auronext Pharma

Form 483FOIA Uncovered

IndiaIssued March 06, 2018

View FDA's Record for This Firm

Source: Third-party index, not matched to FDA. This record came from a third-party Form 483 index rather than from FDA directly, and we have not been able to match it to a document or an inspection FDA publishes. It stays out of the default view for that reason.

ObservationsNot available

Issue DateMarch 06, 2018

StatusWarning Letter Issued

Related Inspections0

Establishment Details

Firm: Auronext Pharma
Location: India
FEI Number: N/A
Issue Date: March 06, 2018
Country: India

Inspection History

We hold no FDA inspection matched to this establishment.

Act on This Form 483

FDA Inspection ReadinessSee how your operations would hold up to the same scrutiny.CAPA & InvestigationsScore how you would investigate and close findings like these.Talk to a SpecialistWalk through these observations with a ComplianceQuest expert.

Auronext Pharma FDA Form 483, March 6, 2018